ConductScience.org, home

Paper31337191

Certain Killer Immunoglobulin-Like Receptor (KIR)/KIR HLA Class I Ligand Genotypes Influence Natural Killer Antitumor Activity in Myelogenous Leukemia but Not in Acute Lymphoblastic Leukemia: A Case Control Leukemia Association Study

Varbanova VP and 3 others. Turk J Haematol, 2019. Cited by 14 papers, by iCite.

Cite this record

ConductScience Library. Certain Killer Immunoglobulin-Like Receptor (KIR)/KIR HLA Class I Ligand Genotypes Influence Natural Killer Antitumor Activity in Myelogenous Leukemia but Not in Acute Lymphoblastic Leukemia: A Case Control Leukemia Association Study. Papers, record 31337191. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31337191

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Certain Killer Immunoglobulin-Like Receptor (KIR)/KIR HLA Class I Ligand Genotypes Influence Natural Killer Antitumor Activity in Myelogenous Leukemia but Not in Acute Lymphoblastic Leukemia: A Case Control Leukemia Association Study
PubMed
Journal
Turk J Haematol
PubMed
Year
2019
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
14
iCite
Relative citation ratio, by iCite
0.7
iCite
Revised in PubMed
2026-05-22
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Varbanova VPViktoria Plamenovahttps://orcid.org/0000-0003-2990-4313
2Mihailova SSnejinahttps://orcid.org/0000-0002-6546-4872
3Naumova EElissavetahttps://orcid.org/0000-0003-3889-8955
4Mihaylova APAnastasiya Petrovahttps://orcid.org/0000-0002-2332-2120

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Genes, MHC Class IMajor topic
Killer Cells, NaturalMajor topic
Leukemia, Myelogenous, Chronic, BCR-ABL PositiveMajor topic
Receptors, KIRMajor topic
Precursor Cell Lymphoblastic Leukemia-LymphomaMajor topic
Female
Humans
Male
Middle Aged
Case-Control Studies
Genetic Predisposition to Disease
Genotype
Healthy Volunteers
Ligands

Source PubMed

Download CSV of topics

References37

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
126983546The favorable role of homozygosity for killer immunoglobulin-like receptor (KIR) A haplotype in patients with advanced-stage classic Hodgkin lymphoma.J Hematol Oncol2016https://conductscience.org/library/papers/26983546PubMed
29126959A single amino acid in the p58 killer cell inhibitory receptor controls the ability of natural killer cells to discriminate between the two groups of HLA-C allotypes.J Immunol1997https://conductscience.org/library/papers/9126959PubMed
39768753Kinetics of interaction of HLA-C ligands with natural killer cell inhibitory receptors.Immunity1998https://conductscience.org/library/papers/9768753PubMed
417476328Association of killer cell immunoglobulin-like receptor genes with Hodgkin's lymphoma in a familial study.PLoS One2007https://conductscience.org/library/papers/17476328PubMed
524078689Large spectrum of HLA-C recognition by killer Ig-like receptor (KIR)2DL2 and KIR2DL3 and restricted C1 SPECIFICITY of KIR2DS2: dominant impact of KIR2DL2/KIR2DS2 on KIR2D NK cell repertoire formation.J Immunol2013https://conductscience.org/library/papers/24078689PubMed
627446203The Impact of KIR Polymorphism on the Risk of Developing Cancer: Not as Strong as Imagined?Front Genet2016https://conductscience.org/library/papers/27446203PubMed
715070694Down-regulation of HLA-A and HLA-Bw6, but not HLA-Bw4, allospecificities in leukemic cells: an escape mechanism from CTL and NK attack?Blood2004https://conductscience.org/library/papers/15070694PubMed
819493232Killer immunoglobulin-like receptors (KIR2DL2 and/or KIR2DS2) in presence of their ligand (HLA-C1 group) protect against chronic myeloid leukaemia.Tissue Antigens2009https://conductscience.org/library/papers/19493232PubMed
912689936Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors.Blood2003https://conductscience.org/library/papers/12689936PubMed
1019450876Killer cell immunoglobulin-like receptor gene polymorphisms in patients with leukemia: possible association with susceptibility to the disease.Leuk Res2010https://conductscience.org/library/papers/19450876PubMed
117532677The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor.J Exp Med1995https://conductscience.org/library/papers/7532677PubMed
1224518758The role of KIR genes and their cognate HLA class I ligands in childhood acute lymphoblastic leukemia.Blood2014https://conductscience.org/library/papers/24518758PubMed
1326472014Genetic associations of killer immunoglobulin like receptors and class I human leukocyte antigens on childhood acute lymphoblastic leukemia among north Indians.Hum Immunol2016https://conductscience.org/library/papers/26472014PubMed
1425281696NK cell genotype and phenotype at diagnosis of acute lymphoblastic leukemia correlate with postinduction residual disease.Clin Cancer Res2014https://conductscience.org/library/papers/25281696PubMed
157716543Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells.Science1995https://conductscience.org/library/papers/7716543PubMed
1617617576KIR2DS1-positive NK cells mediate alloresponse against the C2 HLA-KIR ligand group in vitro.J Immunol2007https://conductscience.org/library/papers/17617576PubMed
1721726204KIR/HLA gene combinations influence susceptibility to B-cell chronic lymphocytic leukemia and the clinical course of disease.Tissue Antigens2011https://conductscience.org/library/papers/21726204PubMed
1815973456A defined donor activating natural killer cell receptor genotype protects against leukemic relapse after related HLA-identical hematopoietic stem cell transplantation.Leukemia2005https://conductscience.org/library/papers/15973456PubMed
1920124216Donor activating KIR3DS1 is associated with decreased acute GVHD in unrelated allogeneic hematopoietic stem cell transplantation.Blood2010https://conductscience.org/library/papers/20124216PubMed
2010381530Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation.Blood1999https://conductscience.org/library/papers/10381530PubMed

See all 37 referencesDownload CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.

PMIDTitleJournalYearIn PapersSource
42453788Parental KIR/HLA-C Profiles and Reproductive Failure: A Phenotype-Stratified Retrospective Analysis of Couples With Fertility Disorders.Obstet Gynecol Int2026https://conductscience.org/library/papers/42453788PubMed
40244151The Role of Killer Ig-like Receptors in Diseases from A to Z.Int J Mol Sci2025https://conductscience.org/library/papers/40244151PubMed
39828905Association of killer immunoglobulin-like receptor genotypes and haplotypes with acute lymphoblastic leukemia risk.Innate Immun2025https://conductscience.org/library/papers/39828905PubMed
37454198Association of killer cell immunoglobulin-like receptors and their cognate HLA class I ligands with susceptibility to acute myeloid leukemia in Iranian patients.Sci Rep2023https://conductscience.org/library/papers/37454198PubMed
37228595NK cell defects: implication in acute myeloid leukemia.Front Immunol2023https://conductscience.org/library/papers/37228595PubMed
36699439Frequency of HLA alleles and KIR Ligands in Acute Myeloid Leukemia in Indian Cohort.Indian J Hematol Blood Transfus2023https://conductscience.org/library/papers/36699439PubMed
32311889[Effect of KIR/HLA receptor-ligand mode on prognosis of single unrelated cord blood transplantation in patients with hematological malignancies].Zhonghua Xue Ye Xue Za Zhi2020https://conductscience.org/library/papers/32311889PubMed

Download CSV of cited by

Genes17

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
HLA-A3105PubTator's text mininghttps://conductscience.org/library/genes/3105NCBI Gene
HLA-B3106PubTator's text mininghttps://conductscience.org/library/genes/3106NCBI Gene
HLA-C3107PubTator's text mininghttps://conductscience.org/library/genes/3107NCBI Gene
ID23398PubTator's text mininghttps://conductscience.org/library/genes/3398NCBI Gene
KIR2DL13802PubTator's text mininghttps://conductscience.org/library/genes/3802NCBI Gene
KIR2DL23803PubTator's text mininghttps://conductscience.org/library/genes/3803NCBI Gene
KIR2DL43805PubTator's text mininghttps://conductscience.org/library/genes/3805NCBI Gene
KIR2DL5A57292PubTator's text mininghttps://conductscience.org/library/genes/57292NCBI Gene
KIR2DL5B553128PubTator's text mininghttps://conductscience.org/library/genes/553128NCBI Gene
KIR2DS13806PubTator's text mininghttps://conductscience.org/library/genes/3806NCBI Gene
KIR2DS2100132285PubTator's text mininghttps://conductscience.org/library/genes/100132285NCBI Gene
KIR2DS33808PubTator's text mininghttps://conductscience.org/library/genes/3808NCBI Gene
KIR2DS43809PubTator's text mininghttps://conductscience.org/library/genes/3809NCBI Gene
KIR2DS53810PubTator's text mininghttps://conductscience.org/library/genes/3810NCBI Gene
KIR3DL13811PubTator's text mininghttps://conductscience.org/library/genes/3811NCBI Gene
KIR3DL23812PubTator's text mininghttps://conductscience.org/library/genes/3812NCBI Gene
KIR3DS13813PubTator's text mininghttps://conductscience.org/library/genes/3813NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/31337191

GET https://conductscience.org/api/papers/v1/31337191/references?page=2